In addition, adverse pregnancy outcomes have been associated with low levels of PAPP-A, for example an increased risk of intrauterine growth restriction, extremely premature delivery, preeclampsia, and stillbirth36. This evidence concerns the gene PAPPA and fetal growth restriction.